Intrigued by recent reports on increased AR-V7 expression in prostate cancer and epithelial cells as a result of NF-κB activation [29,34], we have also tested whether melatonin can inhibit AR-V7 mRNA expression induced by activation of NF-κB signaling in LNCaP cells. This evidence concerns the gene NFKB1 and prostate carcinoma.